• Niclosamide: Applied STAT3 Inhibition for Advanced Cancer Wo

  2026-06-15

  Niclosamide (5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) stands out as a potent STAT3 signaling pathway inhibitor, enabling precise cell cycle and apoptosis studies in cancer research. This article details experimental workflows, troubleshooting strategies, and unique assay insights driven by recent literature and comparative platform analysis.

• RAB31 Regulates an ESCRT-Independent Exosome Biogenesis Path

  2026-06-15

  This study uncovers RAB31 as a critical regulator of exosome formation via an ESCRT-independent mechanism. By elucidating RAB31's dual roles in ILV formation and lysosomal avoidance, the work advances understanding of exosome biogenesis and suggests new molecular targets for studying vesicle trafficking and protein sorting.

• Cy5 TSA Amplification: Redefining Sensitivity in Spatial Bio

  2026-06-14

  Explore how the Cy5 Tyramide Signal Amplification (TSA) Fluorescence System Kit revolutionizes the detection of low-abundance targets in advanced spatial biology and transcriptomics. This article provides mechanistic insights, strategic guidance for translational teams, and actionable protocol tips, bridging state-of-the-art astrocyte heterogeneity mapping with high-sensitivity fluorescent labeling. Learn how horseradish peroxidase catalyzed tyramide deposition, as implemented in APExBIO's Cy5 TSA kit, empowers next-generation research.

• HyperScript RT SuperMix for qPCR: Precision in Spermatogenes

  2026-06-13

  HyperScript RT SuperMix for qPCR enables high-fidelity cDNA synthesis from challenging RNA templates, supporting reliable gene expression analysis in complex models like spermatogenesis under epigenetic stress. Its robust performance with low-concentration and structurally complex RNAs makes it a cornerstone for advancing mechanistic and translational studies.

• TMEM16F in Kupffer Cells Limits Listeria-Induced Liver Injur

  2026-06-12

  This study reveals that TMEM16F, a lipid scramblase expressed in liver Kupffer cells, is critical for protecting against Listeria monocytogenes infection by preserving cell membrane integrity and regulating inflammatory responses. The findings provide mechanistic insight into how host cell membrane repair modulates infection outcomes and liver metabolism.

• Topotecan HCl in DNA Damage and Repair: New Horizons for Onc

  2026-06-12

  Explore how Topotecan HCl, a potent topoisomerase 1 inhibitor, uniquely bridges DNA damage research and antitumor strategies. This article reveals new insights for oncology workflows, highlighting assay design and translational impact.

• CD163+ Macrophage Activation Drives Granulosa Cell Apoptosis

  2026-06-11

  This study elucidates how increased CD163+ macrophage activation and high CD163 expression within ovarian tissue intensify granulosa cell apoptosis, offering mechanistic clarity to the inflammatory contributions underlying polycystic ovary syndrome (PCOS). The findings highlight new potential targets for modulating immune-driven follicular dysfunction and guide future research into therapeutic interventions.

• Trifluoperazine 2HCl: Advancing Dopamine D2 Receptor Researc

  2026-06-11

  Trifluoperazine 2HCl bridges neuropharmacology and immunology by enabling precise dopamine D2 receptor inhibition and revealing novel host-directed antibacterial mechanisms. Its robust solubility and reproducible potency empower advanced dopaminergic signaling and macrophage functional assays, making it indispensable for translational research.

• Dehydroepiandrosterone (DHEA): Atomic Evidence and Protocols

  2026-06-10

  Dehydroepiandrosterone (DHEA) is a validated endogenous steroid hormone that serves as a neuroprotection agent and modulator of ovarian function. APExBIO's DHEA (SKU: B1375) enables reproducible research on apoptosis inhibition and granulosa cell biology. Protocol parameters and benchmarks are provided for precise experimental design.

• Western Secondary Antibody Dilution Buffer: Precision in Pro

  2026-06-10

  Optimize your Western blotting workflow with APExBIO's Western Secondary Antibody Dilution Buffer, engineered for superior signal clarity and cost-effective antibody use. This buffer tackles non-specific binding and enhances reproducibility, making it ideal for high-impact research in inflammation and atherosclerosis.

• PDHA1 Succinylation, α-KGA Accumulation, and Macrophage Supp

  2026-06-09

  This study reveals how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma alters metabolic flux, leading to accumulation of alpha-ketoglutaric acid (α-KGA) in the tumor microenvironment. The resulting α-KGA buildup suppresses macrophage antigen presentation and promotes immune escape, highlighting metabolic reprogramming as a targetable mechanism for overcoming chemotherapy resistance.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Control of β-Cate

  2026-06-09

  Discover how the G007-LK tankyrase 1/2 inhibitor enables precise modulation of β-catenin degradation in APC mutation colorectal cancer research. This in-depth article goes beyond standard reviews, offering actionable protocols and dissecting new mechanistic insights for advanced Wnt/β-catenin pathway studies.

• Thymoquinone Mitigates Doxorubicin Cardiotoxicity via Nrf2/H

  2026-06-08

  This study provides the first direct evidence that thymoquinone (2-isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione) protects mouse hearts from doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 pathway and attenuating ferroptosis. These findings establish a mechanistic basis for using thymoquinone in preclinical models of chemotherapeutic cardiac injury and inform experimental design for future cardioprotective research.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-06-08

  Jeon et al. report the rational design of novel allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), identifying compound 8c with potent activity and metabolic stability. Their work provides a promising scaffold for metabolic disease intervention and highlights the therapeutic relevance of PDK4 modulation.

• Parallel Control of RNA Pol II by CRL3ARMC5 and Integrator i

  2026-06-07

  Cacioppo et al. (2024) reveal that CRL3ARMC5 ubiquitin ligase and Integrator phosphatase independently regulate the abundance and quality of RNA polymerase II (RNA Pol II) complexes at early transcription stages. This work uncovers parallel, complementary pathways that maintain transcriptional fidelity, with implications for studying transcription regulation and targeted inhibition in cancer biology.

11317 records 1/755 page Next 12345 下5页 Last page